Research Seminar with Deirdre Weymann (Simon Fraser University, Canada)

"Real-World Evidence and Life-Cycle Health Technology Assessment: A Case Study of Entrectinib in NTRK Fusion positive Solid Tumours" – Adjunct professor Deirdre Weymann from Simon Fraser University (Canada) will be presenting her research on a precision oncology case study. Precision health technologies frequently lack comparative evidence of safety, effectiveness, and value, challenging conventional regulatory and reimbursement processes and delaying patient access. This seminar presents a life-cycle health technology assessment framework for addressing this evidentiary uncertainty grounded in real-world evidence generated within healthcare systems. The presentation centres on a case study application to entrectinib, a TRK-inhibitor with conditional authorization for tumour-agnostic use in NTRK fusion positive solid tumours.

Lecture in English